Skip to Main Content

Author Details

Robert Deans
Synthego Corporation
1978
91
40
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37738970SARS-CoV-2 variants evolve convergent strategies to remodel the host response.Cell2023
34255899Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity.Stem Cells2021
34539651Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects <i>via</i> Adult Progenitor Cell Co-Culture.Front Immunol2021
29267140Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.Stem Cells Dev2018
31011198Biomanufacturing for clinically advanced cell therapies.Nat Biomed Eng2018
28785285Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells.Stem Cells Int2017
26724220International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.Cytotherapy2016
26596503Current perspectives on the use of ancillary materials for the manufacture of cellular therapies.Cytotherapy2016
27382370Manufacturing Cells for Clinical Use.Stem Cells Int2016
27493716Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process.J Tissue Eng2016
26719206Part 5: Unproven cell therapies and the commercialization of cell-based products.Cytotherapy2016
27079323Adult adherent cell therapy for ischemic stroke: clinical results and development experience using MultiStem.Transfusion2016
27075768Using miRNA-mRNA Interaction Analysis to Link Biologically Relevant miRNAs to Stem Cell Identity Testing for Next-Generation Culturing Development.Stem Cells Transl Med2016
25388385Culturing protocols for human multipotent adult stem cells.Methods Mol Biol2015
26276000Towards the creation of a standard MSC line as a calibration tool.Cytotherapy2015
26589750Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.Cytotherapy2015
26377390Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.Stem Cell Res Ther2015
26582249Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury.Sci Rep2015
26494783Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells.Stem Cells Transl Med2015
26700169Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain.J Neuroinflammation2015
26041737First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation.Stem Cells Transl Med2015
26216515Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2.Mol Ther2015
25555450Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.Biol Blood Marrow Transplant2015
24176542Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII.Cytotherapy2014
25671090Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study.Transplant Res2014
24670268Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep.Stem Cell Res Ther2014
24397853Adult adherent stromal cells in the management of graft-versus-host disease.Expert Opin Biol Ther2014
24422625Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation.Stem Cells Dev2014
23031260Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.Cell Transplant2013
23836805Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression.Stem Cells Transl Med2013
23981727Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis.Stem Cells Transl Med2013
23634984The commercialization of regenerative medicine into a routine healthcare offering. Interview by Emily Culme-Seymour.Regen Med2013
23547116Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.J Immunol2013
22004910Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction.Cell Transplant2012
23205020Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.Front Immunol2012
23210816Regulation, manufacturing and building industry consensus.Regen Med2012
23151227Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation.Trials2012
22687190Development of a surrogate angiogenic potency assay for clinical-grade stem cell production.Cytotherapy2012
22472595Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I).Cell Transplant2012
22642335The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.Immunotherapy2012
22228625Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.Blood2012
21273569Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II.Stroke2011
26998401Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus.Cell Med2011
21999371Commercialization of trials for peripheral artery disease.Cytotherapy2011
21798013Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I).J Transl Med2011
21248119Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury.J Neurosci2011
20018250Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.Biol Blood Marrow Transplant2010
20942603A changing time: the International Society for Cellular Therapy embraces its industry members.Cytotherapy2010
20637752Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes.Exp Neurol2010
20606604Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).Transplantation2010
  • 1 - 50 of 91

Recommended Authors

Vineet Gupta
Purdue University
Career Start Year 1999
Number of shared co-authors 0
Pampee P Young
Vanderbilt University Medical Center
Career Start Year 1996
Number of shared co-authors 1
Nam D Tran
Moffitt Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Manish J Butte
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 0
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 1
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 2
Hiroshi Kawamoto
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 0
Carl Anthony Blau
Center for Cancer Innovation, University of Washington
Career Start Year 1991
Number of shared co-authors 1
Claudia Giachino
University of Turin
Career Start Year 1991
Number of shared co-authors 1
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Career Start Year 1990
Number of shared co-authors 1
Fabio M V Rossi
University of British Columbia
Career Start Year 1990
Number of shared co-authors 0
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 1
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 1
William L Stanford
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 2
Jennifer Soto
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 0
Peter W Marks
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 1
Dirk Strunk
Cell Therapy Institute, Paracelsus Medical University (PMU)
Career Start Year 1987
Number of shared co-authors 0
Marie Csete
University of Southern California Keck School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 2
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 2
George F Tidmarsh
La Jolla Pharmaceutical Company
Career Start Year 1983
Number of shared co-authors 0
Wolfgang Wagner
Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD)
Career Start Year 1983
Number of shared co-authors 1
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 18
George Q Daley
Boston Children's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 6
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 3
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 2
Luigi Naldini
Vita-Salute San Raffaele University
Career Start Year 1980
Number of shared co-authors 4
Brian Seed
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 0
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 4
Anthony P Monaco
Monash University
Career Start Year 1958
Number of shared co-authors 1

Collaborators

Richard T Maziarz
Oregon Health & Science University
Co-authored papers 9
Mahendra S Rao
Institute of Stem Cells and Regenerative Medicine (inStem)
Co-authored papers 3
Frank C Marini
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
Co-authored papers 2
Ralph S Baric
University of North Carolina
Co-authored papers 2
Laura F Newell
Oregon Health and Science University
Co-authored papers 2
Larry L David
Oregon Health and Science University
Co-authored papers 2
Phillip A Wilmarth
Oregon Health & Science University
Co-authored papers 2
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 2
Stanley Thomas Carmichael
David Geffen School of Medicine at University of California-Los Angeles
Co-authored papers 1
Alyssa Hoffert
Co-authored papers 1
Giulia Dowgier
The Francis Crick Institute
Co-authored papers 1
Jane Turner
University College London
Co-authored papers 1
Daniel G Anderson
Co-authored papers 1
Jianyi Zhang
University of Alabama at Birmingham, 1670 University Boulevard
Co-authored papers 1
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Sean I Savitz
University of Texas Health Science Center at Houston
Co-authored papers 1
Ignacia Echeverria
University of California san francisco
Co-authored papers 1
Manolis Kellis
Massachusetts Institute of Technology
Co-authored papers 1
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Thomas P Zwaka
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Joanne Kurtzberg
Marcus Center for Cellular Cures, Duke University School of Medicine
Co-authored papers 1
Hubert J M Smeets
Maastricht University Medical Centre+
Co-authored papers 1
Wilhelm Furnon
MRC-University of Glasgow Centre for Virus Research
Co-authored papers 1
Anastasija Cupic
Co-authored papers 1
Roberta Ragazzini
University College London, The Francis Crick Institute
Co-authored papers 1
Ruth H??ttenhain
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 1
Erica Stevenson
Co-authored papers 1
Shirley M Taylor
Massey Cancer Center
Co-authored papers 1
Release 1.2